SES AUA 2026: First Results from CORE-008 Cohort A: A Phase 2 Study of Intravesical Cretostimogene Grenadenorepvec in Patients with High Risk BCG-Naïve NMIBC UroToday
SES AUA 2026: First Results from CORE-008 Cohort A: A Phase 2 Study of Intravesical Cretostimogene Grenadenorepvec in Patients with High Risk BCG-Naïve NMIBC UroToday